PAPER Singh-Reilly N, Pham NT, Graff-Radford J, Machulda MM, Spychalla AJ, Senjem ML, Petersen RC, Lowe VJ, Boeve BF, Jack CR Jr, Josephs KA, Kantarci K, Whitwell JL
SEARCH RESULTS
482 RESULTS
PAPER Wiesenfarth M, Forouhideh-Wiesenfarth Y, Elmas Z, Parlak Ö, Weiland U, Herrmann C, Schuster J, Freischmidt A, Müller K, Siebert R, Günther K, Fröhlich E, Knehr A, Simak T, Bachhuber F, Regensburger M, Petri S, Klopstock T, Reilich P, Schöberl F, Schumann P, Körtvélyessy P, Meyer T, Ruf WP, Witzel S, Tumani H, Brenner D, Dorst J, Ludolph AC
Correction: Clinical characterization of common pathogenic variants of SOD1-ALS in Germany.
J Neurol. 2025 Mar 8;272(4):259. PubMed. Corrected paper.PAPER Wang H, Chang TS, Dombroski BA, Cheng PL, Si YQ, Tucci A, Patil V, Valiente-Banuet L, Li C, Farrell K, Mclean C, Molina-Porcel L, Rajput A, De Deyn PP, Le Bastard N, Gearing M, Donker Kaat L, Van Swieten JC, Dopper E, Ghetti BF, Newell KL, Troakes C, de Yébenes JG, Rábano-Gutierrez A, Meller T, Oertel WH, Respondek G, Stamelou M, Arzberger T, Roeber S, Müller U, Hopfner F, Pastor P, Brice A, Durr A, Le Ber I, Beach TG, Serrano GE, Hazrati LN, Litvan I, Rademakers R, Ross OA, Galasko D, Boxer AL, Miller BL, Seeley WW, Van Deerlin VM, Lee EB, White CL 3rd, Morris HR, de Silva R, Crary JF, Goate AM, Friedman JS, Compta Y, Leung YY, Coppola G, Naj AC, Wang LS, PSP Genetics Study Group, Dalgard C, Dickson DW, Höglinger GU, Tzeng JY, Geschwind DH, Schellenberg GD, Lee WP
Copy Number Variation and Haplotype Analysis of 17q21.31 Reveals Increased Risk Associated with Progressive Supranuclear Palsy and Gene Expression Changes in Neuronal Cells.
Mov Disord. 2025 Mar 8; Epub 2025 Mar 8 PubMed.PAPER Goldberg YP, Navon-Perry L, Cruz-Herranz A, Chen K, Hecker-Barth G, Spiegel K, Cohen Y, Niethammer M, Tan AM, Schuring H, Geva M, Hayden MR
The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's Disease.
CNS Drugs. 2025 Mar 7; Epub 2025 Mar 7 PubMed.PAPER Gang C, Chen C
Age at diagnosis of obstructive sleep apnea and subsequent risk of dementia.
J Psychiatr Res. 2024 May 24;184:170-175. Epub 2024 May 24 PubMed.PAPER Mesias A, Borges S, Pintado M, Baptista-Silva S
Bioactive peptides as multipotent molecules bespoke and designed for Alzheimer's disease.
Neuropeptides. 2025 Mar 4;111:102515. Epub 2025 Mar 4 PubMed.PAPER Kahn OI, Dominguez SL, Glock C, Hayne M, Vito S, Sengupta Ghosh A, Adrian M, Burgess BL, Meilandt WJ, Friedman BA, Hoogenraad CC
Secreted neurofilament light chain after neuronal damage induces myeloid cell activation and neuroinflammation.
Cell Rep. 2025 Mar 7;44(3):115382. Epub 2025 Mar 7 PubMed.PAPER Lu Q, Shao N, Fang Z, Ouyang Z, Shen Y, Yang R, Liu H, Cai B, Wei T
The anti-Alzheimer's disease effects of ganoderic acid A by inhibiting ferroptosis-lipid peroxidation via activation of the NRF2/SLC7A11/GPX4 signaling pathway.
Chem Biol Interact. 2025 Mar 5;412:111459. Epub 2025 Mar 5 PubMed.PAPER Parhizkar S, Holtzman DM
The night's watch: Exploring how sleep protects against neurodegeneration.
Neuron. 2025 Feb 27; Epub 2025 Feb 27 PubMed.PAPER Tserennadmid B, Nam MK, Park JH, Rhim H, Kang S
HAP/ClpP-mediated disaggregation and degradation of Mutant SOD1 aggregates: A potential therapeutic strategy for Amyotrophic lateral sclerosis (ALS).
Biochem Biophys Res Commun. 2025 Feb 28;756:151533. Epub 2025 Feb 28 PubMed.Leon French on Sex Differences in Blood of Alzheimer’s and Parkinson’s Patients
COMMENT I commend Grandke et al. for highlighting that their strongest pathway-level signal, "SRP-dependent cotranslational protein targeting to membrane," aligns with the gingipain hypothesis. This pathway primarily comprises ribosomal proteins, e.g. R
PAPER Avey DR, Ng B, Vialle RA, Kearns NA, Lopes Kd, Iatrou A, Tissera SD, Vyas H, Saunders DM, Flood DJ, Xu J, Tasaki S, Gaiteri C, Bennett DA, Wang Y
Uncovering Plaque-Glia Niches in Human Alzheimer's Disease Brains Using Spatial Transcriptomics
bioRxiv2024.09.05.611566 .PSEN1 Q223K
MUTATIONS PSEN1 73659470 GRCh37/hg19 rs1898776259 C A 73192762 GRCh38/hg38 rs1898776259 C A Exon 7 Coding Increased Aβ42 levels and the Aβ42/Aβ40 ratio in cells. Unknown. Q223K Alzheimer's Disease: Not ClassifiedAlzheimer's Disease Detailed information on
PSEN1 W165L
MUTATIONS PSEN1 73653574 GRCh37/hg19 rs1898534725 G T 73186866 GRCh38/hg38 G T Exon 6 Coding Unknown, but predicted deleterious in silico (PHRED-scaled CADD score = 28.3). Unknown. W165L Alzheimer's Disease: Not ClassifiedAlzheimer's Disease Detailed info
Yizhou A. Liu
Washington University in St Louis School of MedicineUnited States
Current Filters
- Date Range : Mar 2025 to Mar 2025 x